44 results
424B5
NNVC
NanoViricides Inc
4 Aug 23
Prospectus supplement for primary offering
5:54pm
of bio-defense drugs through NIH funding, the review process by the FDA and the final government procurement contracting authority. While this may
424B5
rjsx88bi sv
31 Jul 20
Prospectus supplement for primary offering
5:29pm
424B5
sicytp44n7
9 Jul 20
Prospectus supplement for primary offering
5:13pm
424B5
lz6y65
8 Jul 20
Prospectus supplement for primary offering
9:57pm
424B5
3nhva32v9
21 May 20
Prospectus supplement for primary offering
9:21pm
424B1
x5ek aq9p6e
23 Jan 20
Prospectus with pricing info
9:04pm
S-1
kggjuk so3sv
28 Sep 19
IPO registration
3:07am